Share Twitter Bluesky Facebook Intel: 60x Earnings Is Too Much For An Unfinished Turnaround 60x Earnings intel Turnaround unfinished
Kala Bio signs exclusive US distribution deal with Virotek for ophthalmology genetic testingSeptember 10, 2026